209 related articles for article (PubMed ID: 31392792)
1. Theaflavin-3,3´-digallate increases the antibacterial activity of β-lactam antibiotics by inhibiting metallo-β-lactamase activity.
Teng Z; Guo Y; Liu X; Zhang J; Niu X; Yu Q; Deng X; Wang J
J Cell Mol Med; 2019 Oct; 23(10):6955-6964. PubMed ID: 31392792
[TBL] [Abstract][Full Text] [Related]
2. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing
Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY
Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231
[TBL] [Abstract][Full Text] [Related]
3. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.
Farhat N; Gupta D; Ali A; Kumar Y; Akhtar F; Kulanthaivel S; Mishra P; Khan F; Khan AU
Microbiol Spectr; 2022 Oct; 10(5):e0045022. PubMed ID: 36069578
[TBL] [Abstract][Full Text] [Related]
4. Cyclic Boronates Inhibit All Classes of β-Lactamases.
Cahill ST; Cain R; Wang DY; Lohans CT; Wareham DW; Oswin HP; Mohammed J; Spencer J; Fishwick CW; McDonough MA; Schofield CJ; Brem J
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115348
[TBL] [Abstract][Full Text] [Related]
5.
Lomovskaya O; Castanheira M; Lindley J; Rubio-Aparicio D; Nelson K; Tsivkovski R; Sun D; Totrov M; Loutit J; Dudley M
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0044023. PubMed ID: 37800963
[TBL] [Abstract][Full Text] [Related]
6. Metallo-β-lactamase inhibitors: A continuing challenge for combating antibiotic resistance.
Kang SJ; Kim DH; Lee BJ
Biophys Chem; 2024 Jun; 309():107228. PubMed ID: 38552402
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial and Sporicidal Activity Evaluation of Theaflavin-3,3'-digallate.
Yussof A; Cammalleri B; Fayemiwo O; Lopez S; Chu T
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216265
[TBL] [Abstract][Full Text] [Related]
8. Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.
Somboro AM; Osei Sekyere J; Amoako DG; Essack SY; Bester LA
Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006399
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial metallopolymers and their bioconjugates with conventional antibiotics against multidrug-resistant bacteria.
Zhang J; Chen YP; Miller KP; Ganewatta MS; Bam M; Yan Y; Nagarkatti M; Decho AW; Tang C
J Am Chem Soc; 2014 Apr; 136(13):4873-6. PubMed ID: 24628053
[TBL] [Abstract][Full Text] [Related]
10. Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA.
Gonzales PR; Pesesky MW; Bouley R; Ballard A; Biddy BA; Suckow MA; Wolter WR; Schroeder VA; Burnham CA; Mobashery S; Chang M; Dantas G
Nat Chem Biol; 2015 Nov; 11(11):855-61. PubMed ID: 26368589
[TBL] [Abstract][Full Text] [Related]
11. Suppression of β-Lactam Resistance by Aspergillomarasmine A Is Influenced by both the Metallo-β-Lactamase Target and the Antibiotic Partner.
Rotondo CM; Sychantha D; Koteva K; Wright GD
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932375
[TBL] [Abstract][Full Text] [Related]
12. Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes.
Hinchliffe P; González MM; Mojica MF; González JM; Castillo V; Saiz C; Kosmopoulou M; Tooke CL; Llarrull LI; Mahler G; Bonomo RA; Vila AJ; Spencer J
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3745-54. PubMed ID: 27303030
[TBL] [Abstract][Full Text] [Related]
13. Progress toward inhibitors of metallo-β-lactamases.
McGeary RP; Tan DT; Schenk G
Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
[TBL] [Abstract][Full Text] [Related]
14. Metallo-β-lactamase-mediated antimicrobial resistance and progress in inhibitor discovery.
Yang Y; Yan YH; Schofield CJ; McNally A; Zong Z; Li GB
Trends Microbiol; 2023 Jul; 31(7):735-748. PubMed ID: 36858862
[TBL] [Abstract][Full Text] [Related]
15. Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.
Palacios AR; Rossi MA; Mahler GS; Vila AJ
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32503337
[TBL] [Abstract][Full Text] [Related]
16. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
[TBL] [Abstract][Full Text] [Related]
17. Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers.
Brem J; van Berkel SS; Zollman D; Lee SY; Gileadi O; McHugh PJ; Walsh TR; McDonough MA; Schofield CJ
Antimicrob Agents Chemother; 2016 Jan; 60(1):142-50. PubMed ID: 26482303
[TBL] [Abstract][Full Text] [Related]
18. The Development of New Small-Molecule Inhibitors Targeting Bacterial Metallo-β-lactamases.
Wang P; Cheng J; Liu CC; Tang K; Xu F; Yu Z; Yu B; Chang J
Curr Top Med Chem; 2018; 18(10):834-843. PubMed ID: 29773066
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus-targeting peptide/surfactant assemblies for antibacterial therapy.
Jiang J; Xu Z; Chen J; Xu Z; Huang Y; Xi J; Fan L
Colloids Surf B Biointerfaces; 2022 Jun; 214():112444. PubMed ID: 35278861
[TBL] [Abstract][Full Text] [Related]
20. Genomic identification of cryptic susceptibility to penicillins and β-lactamase inhibitors in methicillin-resistant Staphylococcus aureus.
Harrison EM; Ba X; Coll F; Blane B; Restif O; Carvell H; Köser CU; Jamrozy D; Reuter S; Lovering A; Gleadall N; Bellis KL; Uhlemann AC; Lowy FD; Massey RC; Grilo IR; Sobral R; Larsen J; Rhod Larsen A; Vingsbo Lundberg C; Parkhill J; Paterson GK; Holden MTG; Peacock SJ; Holmes MA
Nat Microbiol; 2019 Oct; 4(10):1680-1691. PubMed ID: 31235959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
